145 related articles for article (PubMed ID: 36541848)
1. Delayed haemolytic transfusion reaction in paediatric patients with sickle cell disease: A retrospective study in a French national reference centre.
Rossi M; Pirenne F; Le Roux E; Smaïne D; Belloy M; Eyssette-Guerreau S; Couque N; Holvoet L; Ithier G; Brousse V; Koehl B; Faye A; Benkerrou M; Missud F
Br J Haematol; 2023 Apr; 201(1):125-132. PubMed ID: 36541848
[TBL] [Abstract][Full Text] [Related]
2. Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
Gerritsma J; Bongaerts V; Eckhardt C; Heijboer H; Nur E; Biemond B; van der Schoot E; Fijnvandraat K;
Br J Haematol; 2022 Feb; 196(3):769-776. PubMed ID: 34632580
[TBL] [Abstract][Full Text] [Related]
3. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
Gardner K; Hoppe C; Mijovic A; Thein SL
Br J Haematol; 2015 Sep; 170(6):745-56. PubMed ID: 25967919
[TBL] [Abstract][Full Text] [Related]
4. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.
Vidler JB; Gardner K; Amenyah K; Mijovic A; Thein SL
Br J Haematol; 2015 Jun; 169(5):746-53. PubMed ID: 25753472
[TBL] [Abstract][Full Text] [Related]
5. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
Fortin PM; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
[TBL] [Abstract][Full Text] [Related]
7. Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.
Habibi A; Mekontso-Dessap A; Guillaud C; Michel M; Razazi K; Khellaf M; Chami B; Bachir D; Rieux C; Melica G; Godeau B; Galacteros F; Bartolucci P; Pirenne F
Am J Hematol; 2016 Oct; 91(10):989-94. PubMed ID: 27348613
[TBL] [Abstract][Full Text] [Related]
8. Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.
Narbey D; Habibi A; Chadebech P; Mekontso-Dessap A; Khellaf M; Lelièvre JD; Godeau B; Michel M; Galactéros F; Djoudi R; Bartolucci P; Pirenne F
Am J Hematol; 2017 Dec; 92(12):1340-1348. PubMed ID: 28924974
[TBL] [Abstract][Full Text] [Related]
9. The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease.
Noizat-Pirenne F; Habibi A; Mekontso-Dessap A; Razazi K; Chadebech P; Mahevas M; Vingert B; Bierling P; Galactéros F; Bartolucci P; Michel M
Vox Sang; 2015 Apr; 108(3):262-7. PubMed ID: 25523469
[TBL] [Abstract][Full Text] [Related]
10. [Delayed haemolytic transfusion reaction: About 3 patients with sickle cell disease].
Bertrand E; Dumesnil C; Lahary A; Al Bagami M; Schneider P; Lévesque H; Vannier JP
Rev Med Interne; 2015 Nov; 36(11):769-72. PubMed ID: 25529378
[TBL] [Abstract][Full Text] [Related]
11. Can we better predict delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease?
Adkins BD; Sharma D; Eichbaum Q
Transfus Apher Sci; 2020 Apr; 59(2):102681. PubMed ID: 31831326
[TBL] [Abstract][Full Text] [Related]
12. Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease: A Case Series.
Alwaheed AJ; Alqatari SG; AlSulaiman AS; AlSulaiman RS
Am J Case Rep; 2022 Jan; 23():e934681. PubMed ID: 34983921
[TBL] [Abstract][Full Text] [Related]
13. Delayed hemolytic transfusion reaction in children with sickle cell disease.
de Montalembert M; Dumont MD; Heilbronner C; Brousse V; Charrara O; Pellegrino B; Piguet C; Soussan V; Noizat-Pirenne F
Haematologica; 2011 Jun; 96(6):801-7. PubMed ID: 21330322
[TBL] [Abstract][Full Text] [Related]
14. Blood transfusion for preventing stroke in people with sickle cell disease.
Riddington C; Wang W
Cochrane Database Syst Rev; 2002; (1):CD003146. PubMed ID: 11869654
[TBL] [Abstract][Full Text] [Related]
15. Anti-s antibody-associated delayed hemolytic transfusion reaction in patients with sickle cell anemia.
Kalyanaraman M; Heidemann SM; Sarnaik AP; Meert KL; Sarnaik SA
J Pediatr Hematol Oncol; 1999; 21(1):70-3. PubMed ID: 10029818
[TBL] [Abstract][Full Text] [Related]
16. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells.
King KE; Shirey RS; Lankiewicz MW; Young-Ramsaran J; Ness PM
Transfusion; 1997 Apr; 37(4):376-81. PubMed ID: 9111274
[TBL] [Abstract][Full Text] [Related]
17. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Wang WC; Dwan K
Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
[TBL] [Abstract][Full Text] [Related]
18. Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition.
Vlachaki E; Gavriilaki E; Kafantari K; Adamidou D; Tsitsikas D; Chasapopoulou E; Anagnostopoulos A; Tsapas A
Hemoglobin; 2018; 42(5-6):339-341. PubMed ID: 30626228
[TBL] [Abstract][Full Text] [Related]
19. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.
Pirenne F; Yazdanbakhsh K
Blood; 2018 Jun; 131(25):2773-2781. PubMed ID: 29724898
[TBL] [Abstract][Full Text] [Related]
20. Preoperative blood transfusions for sickle cell disease.
Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]